The global opioids agonist drugs market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are fuelling the growth of the market include the growing prevalence of pain and diarrhea. Opioids are generally used for treating pain, however, opioid-containing drugs are being misused or are being consumed in overdose when patients follow self-medication. The opioid drug class comprises morphine, hydrocodone, oxycodone, heroin, codeine, morphine, fentanyl, and methadone. It is also employed as a cough suppressant and in diarrhea treatment. Opioids can be administered either through pills, liquids, intravenous, transdermal patches, or lozenges. Developed nations in North America and Europe have high levels of abuse of this drug. Drugs such as codeine, morphine, fentanyl, and hydrocodone have become a source of addiction, especially among the population, owing to the easy availability of drugs in these regions.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/opioids-agonist-drugs-market
However, global organisations as well as regulatory agencies including the FDA, Centers for Disease Control and Prevention (CDC), and World Health Organization (WHO) are working towards restricting the abuse of opioids by creating awareness and educating prescribers to be cautious while prescribing these drugs. In 2016, the CDC issued guidelines to prescribe opioids, limiting the daily dose of opioids to 90 morphine milligram equivalent (MME). In recent years, cannabis has emerged as an alternative for opioids. Cannabis is legalized in many states in the US, as it is considered safer than opioids. Therefore, legalizing cannabis (marijuana) is a factor that is expected to have a detrimental impact on the market growth during the forecast period.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Pfizer Inc., Boehringer Ingelheim GmbH, and Sanofi S.A., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Opioids Agonist Drugs Market Report by Segment
By Product
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Others
By Application
- Pain Management
- Cough Treatment
- Diarrhea Treatment
A full report of Opioids Agonist Drugs Market is available at: https://www.omrglobal.com/industry-reports/opioids-agonist-drugs-market
Opioids Agonist Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Pfizer Inc.
- Boehringer Ingelheim GmbH
- Sanofi S.A.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
